Moreover, high-efficacy monoclonal antibody therapy -- ocrelizumab (Ocrevus), rituximab (Rituxan), or natalizumab (Tysabri) - ...

A new study, commissioned by the Multiple Sclerosis Society of New Zealand (MSNZ), analysed the cost-effectiveness of Ocrelizumab - which got funded as a treatment for primary progressive multiple ...

There is only one treatment approved to-date, in primary progressive MS and that is Ocrelizumab or Ocrevus. But, I also think it’s important to note that, as patients progress, as they, get into these ...

That’s because ocrelizumab temporarily weakens your immune system. Your doctor will watch you for signs of infection after you get the medicine. They'll also ask you to let them know if you ...

The FDA has approved three such drugs for MS. Ocrelizumab (Ocrevus) treats relapsing forms of MS, including: Clinically isolated syndrome Relapsing-remitting MS Active secondary progressive MS in ...

as well as the performances of multiple sclerosis therapy Ocrevus (ocrelizumab) and Hemlibra (emicizumab) for haemophilia. Diagnostic led the charge, rising 24% to CHF 5.3 billion, but pharma also ...

New findings show a similar number of injective-related reactions (IRRs) were reported between the use of ofatumumab (Kesimpta) and ocrelizumab (Ocrevus) in the treatment of multiple sclerosis ...

pitting it against Roche's antibody therapy Ocrevus (ocrelizumab). The drugmaker reported results from the main FENopta trial last year. Fenebrutinib is currently the only reversible, non-covalent ...

A new study, commissioned by the Multiple Sclerosis Society of New Zealand (MSNZ), analysed the cost-effectiveness of Ocrelizumab - which got funded as a treatment for primary progressive multiple ...

Progressive Multifocal Leukoencephalopathy (PML) is a severe, life-threatening condition that poses a particular risk for MS ...

‘A TOADY’: Lau, a Chinese political advisory body member, sparked controversy with his song “Chinese People” and the concert was said to be part of China’s “united front” tactics Employment ...

Even single day's delay in deciding bail plea adversely affects fundamental rights of citizens: SC NEW DELHI: Deprecating the practice of courts keeping bail applications pending for years, the ...